Binding of Candida albicans enolase to plasmin(ogen) results in enhanced invasion of human brain microvascular endothelial cells.

Infection by the human opportunistic fungal pathogen Candida albicans has been increasing over recent years. In an attempt to understand the molecular mechanism of Candida invasion across host tissues, the relationship of C. albicans enolase to human plasminogen/plasmin was investigated. C. albicans enolase is a cell-surface protein and an immunodominant antigen in infected patients' sera. Plasminogen is an abundant plasma protein. Several lines of evidence support the binding of C. albicans enolase to human plasminogen. Firstly, it was found that various Candida strains were able to bind to plasminogen and its active form, plasmin. Secondly, recombinant Candida enolase was retained in a nickel-chelating affinity column matrix that can bind (125)I-labelled plasminogen or plasmin in a dose-dependent manner. Plasmin(ogen)-specific inhibitors, such as epsilon -aminocaproic acid and aprotinin, can effectively block plasmin-binding activity. Thirdly, as with many plasminogen receptors, binding of Candida enolase to plasmin(ogen) is lysine-dependent, whereas little inhibition occurred with arginine, aspartate and glutamate. Fourthly, immobilized enolase enhanced plasminogen's affinity for streptokinase at least tenfold, as demonstrated by its activation of plasmin activity. To elucidate the biological significance of this result, it was demonstrated that the plasmin(ogen)-bound Candida cells were able to induce fibrinolysis activity in a matrix-gel assay. Furthermore, plasmin-bound Candida cells had an increased ability to cross an in vitro blood-brain barrier system. The results given here indicate that Candida enolase is a plasminogen- and plasmin-binding protein and that the interaction of C. albicans enolase with the plasminogen system may contribute to invasion of the tissue barrier.

[1]  M. Rodier,et al.  A Candida albicans metallopeptidase degrades constitutive proteins of extracellular matrix. , 1999, FEMS microbiology letters.

[2]  W. Hop,et al.  Diagnostic value of anti-Candida enolase antibodies , 1994, Journal of clinical microbiology.

[3]  P. Sundstrom,et al.  Adhesins in Candida albicans. , 1999, Current opinion in microbiology.

[4]  P. Belhumeur,et al.  Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase , 1996, Infection and immunity.

[5]  H. Maeda,et al.  Degradation of humoral host defense by Candida albicans proteinase , 1995, Infection and immunity.

[6]  A. Stringaro,et al.  Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics. , 1996, The Journal of infectious diseases.

[7]  U. Hynönen,et al.  Plasminogen receptors. Turning Salmonella and Escherichia coli into proteolytic organisms. , 1997, Advances in experimental medicine and biology.

[8]  E. Tuomanen.  Entry of pathogens into the central nervous system. , 1996, FEMS microbiology reviews.

[9]  S. Klotz,et al.  Expression, cloning, and characterization of a Candida albicans gene, ALA1, that confers adherence properties upon Saccharomyces cerevisiae for extracellular matrix proteins , 1997, Infection and immunity.

[10]  A. Mitchell.  Dimorphism and virulence in Candida albicans. , 1998, Current opinion in microbiology.

[11]  J. Renau‐Piqueras,et al.  The Cell Wall-Associated Glyceraldehyde-3-Phosphate Dehydrogenase of Candida albicans Is Also a Fibronectin and Laminin Binding Protein , 1998, Infection and Immunity.

[12]  T. Nichterlein,et al.  Differential activation of a Candida albicans virulence gene family during infection. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Kanefusa Kato,et al.  Plasminogen Binds Specifically to α‐Enolase on Rat Neuronal Plasma Membrane , 1994 .

[14]  R. Rüchel.  Cleavage of immunoglobulins by pathogenic yeasts of the genus Candida. , 1986, Microbiological sciences.

[15]  N. Gow,et al.  A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence , 1997, Infection and immunity.

[16]  W. D. de Jong,et al.  Tau-crystallin/alpha-enolase: one gene encodes both an enzyme and a lens structural protein , 1988, The Journal of cell biology.

[17]  M. J. Kennedy,et al.  Molecular basis of Candida albicans adhesion. , 1992, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[18]  Timo K. Korhonen,et al.  Bacterial plasminogen receptors: in vitro evidence for a role in degradation of the mammalian extracellular matrix , 1995, Infection and immunity.

[19]  P. T. Magee,et al.  Candida pathogenesis: Unravelling the threads of infection , 1997, Current Biology.

[20]  Jordi Félez,et al.  Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. , 1991, Biochemistry.

[21]  C. Nombela,et al.  Understanding Candida albicans at the Molecular Level , 1996, Yeast.

[22]  M. Ghannoum,et al.  Cloning and Characterization ofCAD1/AAF1, a Gene from Candida albicans That Induces Adherence to Endothelial Cells after Expression inSaccharomyces cerevisiae , 1998, Infection and Immunity.

[23]  H. Chapman,et al.  Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. , 1997, Current opinion in cell biology.

[24]  P. Belhumeur,et al.  Overexpression of Candida albicans secretory aspartyl proteinase 2 and its expression in Saccharomyces cerevisiae do not augment virulence in mice. , 1998, Microbiology.

[25]  T. C. White,et al.  In Vivo Analysis of Secreted Aspartyl Proteinase Expression in Human Oral Candidiasis , 1999, Infection and Immunity.

[26]  A. Jong,et al.  Cellular mechanisms of microbial proteins contributing to invasion of the blood–brain barrier , 2001, Cellular microbiology.

[27]  M. Hostetter.  Linkage of adhesion, morphogenesis, and virulence in Candida albicans. , 1998, The Journal of laboratory and clinical medicine.

[28]  M. Stins,et al.  Citrobacter freundii Invades and Replicates in Human Brain Microvascular Endothelial Cells , 1999, Infection and Immunity.

[29]  J. Berman,et al.  Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. , 1998, Science.

[30]  K. Gase,et al.  Inactivation of the streptokinase gene prevents Streptococcus equisimilis H46A from acquiring cell-associated plasmin activity in the presence of plasminogen. , 1994, FEMS microbiology letters.

[31]  M. Ghannoum,et al.  Cloning and characterization of CAD1/AAF1, a gene from Candida albicans that induces adherence to endothelial cells after expression in Saccharomyces cerevisiae. , 1998, Infection and immunity.

[32]  S. Filler,et al.  Expression of the Candida albicans GeneALS1 in Saccharomyces cerevisiae Induces Adherence to Endothelial and Epithelial Cells , 1998, Infection and Immunity.

[33]  J. Hacker,et al.  Degradation of human subendothelial extracellular matrix by proteinase-secreting Candida albicans. , 1997, FEMS microbiology letters.

[34]  S. Filler,et al.  Secreted Aspartyl Proteinases and Interactions of Candida albicans with Human Endothelial Cells , 1998, Infection and Immunity.

[35]  M. Simon,et al.  COS1, a two-component histidine kinase that is involved in hyphal development in the opportunistic pathogen Candida albicans. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Ghannoum,et al.  Cloning and Disruption of caPLB1, a Phospholipase B Gene Involved in the Pathogenicity of Candida albicans * , 1998, The Journal of Biological Chemistry.

[37]  Steven H. M. Chen,et al.  Traversal of Candida albicans across Human Blood-Brain Barrier In Vitro , 2001, Infection and Immunity.

[38]  A. Cassone,et al.  Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis , 1995, Infection and immunity.

[39]  J. P. Irigoyena,et al.  The plasminogen activator system : biology and regulation , 2022 .

[40]  T. Tuan,et al.  In vitro fibroplasia: matrix contraction, cell growth, and collagen production of fibroblasts cultured in fibrin gels. , 1996, Experimental cell research.

[41]  A. Johnson,et al.  Control of filament formation in Candida albicans by the transcriptional repressor TUP1. , 1997, Science.

[42]  E. Tuomanen,et al.  Molecular and cellular mechanisms for microbial entry into the CNS. , 1999, Journal of neurovirology.

[43]  M. Baker,et al.  The human ENO1 gene product (recombinant human alpha-enolase) displays characteristics required for a plasminogen binding protein. , 1997, Biochimica et biophysica acta.

[44]  J. Brewer,et al.  Characterization of the interaction of yeast enolase with polynucleotides. , 1992, Biochimica et biophysica acta.

[45]  R. Calderone,et al.  Adherence and receptor relationships of Candida albicans. , 1991, Microbiological reviews.

[46]  J Hacker,et al.  Host‐induced, stage‐specific virulence gene activation in Candida albicans during infection , 1999, Molecular microbiology.

[47]  V. Fischetti,et al.  α-Enolase, a Novel Strong Plasmin(ogen) Binding Protein on the Surface of Pathogenic Streptococci* , 1998, The Journal of Biological Chemistry.